← Eichor
Condition: Carbapenem Resistant Bacterial Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Carbapenem Resistant Bacterial Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Phase 4 · 3 location(s) · Rambam Health Care Campus · NCT05922124Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumo
Phase N/A · 1 location(s) · Fujian Medical University Union Hospital · NCT07086391A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Pat
Phase N/A · 1 location(s) · TTY Biopharm · NCT06966284Different Administration Regimens of CAZ-AVI in Combination With ATM for the Treatment of CR-GNB
Phase 4 · 1 location(s) · Jing Zhou · NCT07478484FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
Phase 1/Phase 2 · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT04759001Safety and Efficacy of Fecal Microbiota Transplantation
NA · 1 location(s) · Chinese University of Hong Kong · NCT04014413Therapeutic Options for CRAB
Phase 4 · 1 location(s) · Clinical Hospital Centre Zagreb · NCT06440304Further MT for Antibiotic-Resistant Bacterial Colonization
Phase 2 · 6 location(s) · Emory University · NCT05835206FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
Phase 1/Phase 2 · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05791396Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infecti
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07089186Optimising TREATment for Severe Gram-Negative Bacterial Infections
Phase 4 · 41 location(s) · National University of Singapore · NCT07004049
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.